SCHEMBL7833402

SCHEMBL7833402

CCCn1[c]nc2ncccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.35
ASAH1 Q13510 1/20 0.34
SLC9A1 P19634 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
LTA4H P09960 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33
HTR3A P46098 1/20 0.33
HTR3D Q70Z44 1/20 0.33
HTR3C Q8WXA8 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7837678 0.90 ASAH1 (0.38) ASAH1SLC9A1KDM4EKMT2ALMNA
SCHEMBL5983373 0.88 ASAH1 (0.41) ASAH1SLC9A1KMT2AFAAH
SCHEMBL1853636 0.77 BACE1 (0.39) BACE1KMT2AADORA3ADORA2ALTA4H
SCHEMBL1828029 0.74 SLC9A1 (0.47) SLC9A1KDM4EKMT2ANPC1RAB9A
SCHEMBL3960228 0.69 LTA4H (0.52) ASAH1KDM4EADORA2AADORA1LTA4H
SCHEMBL5982661 0.66 BACE1 (0.40) BACE1ASAH1KDM4EKMT2AADORA3
SCHEMBL5981819 0.64 SLC9A1 (0.50) SLC9A1KMT2APOLBMAPT
SCHEMBL5983132 0.64 BACE1 (0.33) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL3669331 0.64 TLR8 (0.48) ASAH1KDM4EKMT2ALMNAMAPT
SCHEMBL5373386 0.63 SLC9A1 (0.51) SLC9A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed